Khan Matin, MD | |
3701 Lansdowne Dr, Ashland, KY 41101 | |
(606) 324-3005 | |
(606) 329-1530 |
Full Name | Khan Matin |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 3701 Lansdowne Dr, Ashland, Kentucky |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124033931 | NPI | - | NPPES |
64224835 | Medicaid | KY | |
0806677 | Medicaid | OH | |
11101867 | Other | CAQH | |
3402033 | Other | KY | ASHLAND HOSPITAL CORP (KDMC) MEDICARE PTAN |
0114374000 | Medicaid | WV | |
1669101 | Other | KY | INDIVIDUAL MEDICARE PTAN |
1982615043 | Other | KY | PATHWAYS GROUP NPI # |
260031769 | Other | PALMETTO GPA RR MEDICARE | |
30610026 | Medicaid | KY | |
0519303 | Other | KY | MEDICARE PTAN # - PATHWAYS, INC. |
0005355002 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 22483 (Kentucky) | Primary |
2084P0800X | Psychiatry & Neurology - Psychiatry | 35050198 (West Virginia) | Secondary |
Entity Name | Prestera Center For Mental Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356336903 PECOS PAC ID: 9234029307 Enrollment ID: O20040319001328 |
News Archive
Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure today announced that it has completed patient enrollment in its Phase 3 clinical study of vepoloxamer for the treatment of patients with sickle cell disease experiencing vaso-occlusive crisis, known as the EPIC study.
Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body.
The moment when healthy cells turn into cancer cells is a critical point. And if caught early enough, many cancers can be stopped in their tracks.
The Consumer Healthcare Products Association today issued the following statement in response to passage of Senate Bill 437: "Legislation sponsored by Senator Percy Malone and now signed into law places new, onerous burdens on Arkansas families and makes it more difficult for those with common colds and allergies, even basic aches and pains, to get the medications they need. Unfortunately, Senate Bill 437 falls short of the common-sense approach Arkansans expect from their leaders."
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Khan Matin, MD Po Box 790, Ashland, KY 41105-0790 Ph: (606) 329-8588 | Khan Matin, MD 3701 Lansdowne Dr, Ashland, KY 41101 Ph: (606) 324-3005 |
News Archive
Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure today announced that it has completed patient enrollment in its Phase 3 clinical study of vepoloxamer for the treatment of patients with sickle cell disease experiencing vaso-occlusive crisis, known as the EPIC study.
Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body.
The moment when healthy cells turn into cancer cells is a critical point. And if caught early enough, many cancers can be stopped in their tracks.
The Consumer Healthcare Products Association today issued the following statement in response to passage of Senate Bill 437: "Legislation sponsored by Senator Percy Malone and now signed into law places new, onerous burdens on Arkansas families and makes it more difficult for those with common colds and allergies, even basic aches and pains, to get the medications they need. Unfortunately, Senate Bill 437 falls short of the common-sense approach Arkansans expect from their leaders."
› Verified 5 days ago
Mrs. Maya Devi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 | |
Dr. Kathryn Guggenheim, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 617 23rd St, Ashland, KY 41101 Phone: 606-326-0300 Fax: 606-326-0235 | |
Wilma Castro, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 617 23rd St, Suite 12, Ashland, KY 41101 Phone: 606-326-1557 Fax: 606-326-1570 | |
Tanya Catherine Warwick, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St Ste 400, Ashland, KY 41101 Phone: 606-408-2820 Fax: 606-326-0235 | |
Dr. Bal K Bansal, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 700 Saint Christopher Dr Ste 101, Ashland, KY 41101 Phone: 606-836-0604 | |
Brittany Leigh Richardson, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 063-864-6826 |